Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
t z rc eh giek rtrmadp health coronavirus thailand vaccine e

The COVID vaccine race champion appears to be mRNA technology used by Pfizer and Moderna. Here’s a primer

STAT | 
There are about a dozen experimental vaccines in late-stage clinical trials globally, but the ones being tested by Pfizer and Moderna are ...
t

Controversial treatment for dwarfism meets clinical trial goals. Is FDA approval coming?

STAT | 
A treatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the ...
josiah zayner biohacker portrait

Podcast: Talking CRISPR with controversial biohacker Josiah Zayner

STAT | 
Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? ...
low libido in young women

Controversial new drug meant to increase sexual desire in women is approved for sale

STAT | 
The Food and Drug Administration approved a controversial drug meant to increase women’s desire for sex, a treatment that has ...
jruhu tlem hcqkrisrsith e xn padcwad dzro

Biohacker Josiah Zayner meets with California regulators investigating him: ‘It was surreal’

STAT | 
A few weeks ago, the prominent biohacker Josiah Zayner took to Instagram to break some news: He had received a ...
alzheimer’s

Video: Alzheimer’s and the disappointing history of amyloid research

STAT | 
The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, ...
dna tests

Why the results of your genetic ancestry test will change over time

STAT | 
23andMe caused Leonard Kim not one identity crisis but two. The first came in 2016, when Kim, who was raised ...
img

Fine-tuning CAR-T cancer therapy could eliminate serious side effects, study says

STAT | 
A novel approach to CAR-T cancer therapy promises to upend what has become a truism in medicine: that the treatment’s dramatic effect ...
2-18-2019 jim wilson mini e x

Pioneering ‘refugee’ from gene therapy’s darker days ‘kept the faith’

STAT | 
Gene therapy, now a pillar of biotechnology with the potential to cure deadly diseases, was once a cautionary tale of ...
eye

CRISPR treatment for rare genetic eye disorder gains FDA study approval

STAT | 
Days after a Chinese researcher incensed the world of science with claims of editing the genomes of twin girls, an American ...
dementia x

Small patient pool in Alzheimer’s drug trial casts shadow on positive results

STAT | 
Facing pressing questions about its latest clinical trial in Alzheimer’s disease, Biogen may have sowed further doubt on the future ...
Alzheimer’s

Study sparks fresh debate over an old theory on the cause of Alzheimer’s

STAT | 
In the long-running debate over just what causes Alzheimer’s disease, one side looks to have scored a victory with new ...
Alz

Investigational Alzheimer’s drug shows promise

STAT | 
An investigational Alzheimer’s drug significantly slowed patients’ cognitive decline in a large clinical trial, unexpected and unprecedented results that could ...
cancer immunotherapy birak

‘Scientific gold rush’ created by quest for universal immunotherapy

STAT | 
The drug industry has made a mint on immunotherapies for cancer, but those game-changing treatments don’t work for most people’s tumors ...
crispr

CRISPRcon talks designer babies and scientific colonialism

STAT | 
While lacking the costuming of Comic-Con or revelry of SantaCon, [CRISPRCon’s] second annual geek-out dealt with a concept weightier than ...
alzheimers disease

Promising Alzheimer’s drug solanezumab fails late-stage trial, hitting dead end

STAT | 
An investigational Alzheimer’s treatment from Eli Lilly failed to slow the progression of the memory-destroying disease in a late-stage trial, ...
Screen Shot at PM

Bombshell health study: Raising HDL “good” cholesterol does not help prevent heart disease

STAT | 
Raising HDL, widely known as good cholesterol, for years has been thought to protect against heart attack and stroke. But ...
SEM Lymphocyte

Turning body’s own defenses to fight tumors: Does CAR-T work?

STAT | 
There’s new hope that a much-hyped class of immunotherapies could revolutionize cancer treatment...But experts remain cautious about safety and efficacy ...
FDA wings

FDA resumes trial using genetically engineered cancer-killing cells two days after patient deaths

STAT | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Federal regulators on [July ...

Supreme Court ruling threatens value of many biotech patents

STAT | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. On June 27, the ...

Biotech company shooting to cure rare diseases with CRISPR goes public

STAT | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Intellia Therapeutics, a biotech ...
px Assorted pharmaceuticals by LadyofProcrastination

Will doctors prescribe the first approved US copycat biological drug?

Fierce Biotech | 
A group of FDA advisers unanimously recommended approval for Novartis'  knockoff of a blockbuster Amgen treatment, clearing the way for what ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.